Fundraising Fox
/Companies
Sign in

Kojin Therapeutics

Boston, US · Founded 2019 · Delaware corporation · 6 employees on LinkedIn · 4 known investors

Find your way into Kojin Therapeutics

Biotech

Founders & leadership

NM
Nagesh Mahanthappa, Ph.D.Named on SEC filing
LGLuba Greenwood
Luba GreenwoodInvestor, Binney Street Capital2021–2024Business Strategy Advisor at Optic

Board

AN
Amir Nashat, Ph.D.Treasurer and Secretary
SL
Susan LangerPresident
TJThomas J. Cahill
Thomas J. CahillBoard directorManaging Partner at Newpath Partners

Investors · 4

Cathay HealthreportedSan Francisco

How we know: funding news · Not right? Tell us

Newpath PartnersreportedBoston · $50K – $10M

How we know: board seat on SEC Form D · funding news · Not right? Tell us

Polaris PartnersreportedBoston · $500K – $5M

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$30.2M disclosed across 1 round · 2021

▶$30.2MraisedJun 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nagesh Mahanthappa, Ph.D.Director
  • Amir Nashat, Ph.D.Executive Officer, Director
  • Susan LangerExecutive Officer
  • Luba GreenwoodDirector
  • Thomas J. CahillDirector
Offering amount
$60.2M
Amount sold
$30.2M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Kojin Therapeutics's investors?
Kojin Therapeutics's investors include 5AM Ventures, Cathay Health, Newpath Partners, Polaris Partners.
How much funding has Kojin Therapeutics raised?
Kojin Therapeutics has disclosed $30.2M raised across 1 round.
Where is Kojin Therapeutics headquartered?
Kojin Therapeutics is headquartered in Boston, US.